NYR 9.26% 5.9¢ nyrada inc.

Ann: Investor Roadshow Presentation, page-4

  1. 887 Posts.
    lightbulb Created with Sketch. 469
    I struggle to see how NYR beats Merck to market. If I'm not mistaken, Merck had similar efficacy as Nyrada's asset did preclinically, but actually in humans in their Phase I trials. Probably puts them about 2 years ahead? Returns should be there though as you said!
    Last edited by FreeBobby2002: 30/03/22
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $10.75M
Open High Low Value Volume
5.7¢ 5.9¢ 5.7¢ $4.571K 80K

Buyers (Bids)

No. Vol. Price($)
1 172711 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 804500 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.